HK's Jinhai Medical climbs to 12-week high after senior executive appointment

GE HealthCare Technologies

04/08/2026 04:07

** Shares of Jinhai Medical Technology 2225.HK rise 13.4% to HK$4.48, their highest level since May 13
** Stock of Jinhai Medical, a Singapore-based minimally invasive surgery solutions, medical products and related services provider, posts its biggest intraday pct gain since July 3 
** Jinhai Medical, with current market capitalisation of $3.01 billion, announce the appointment of Ma Chengdong as chief marketing officer effective August 3, responsible for marketing and commercialisation of medical devices and equipment products 
** Ma worked on product, technology, marketing and sales at international medical enterprises, including subsidiaries of GE HealthCare Technologies Inc GEHC.O and Medtronic plc MDT.N - co
** "Following the appointment, the group expects that its marketing and promotion capabilities in minimally invasiveness and non-invasiveness will be further improved and strengthened," the company says, adding it possesses advantages to enter into the neurosurgical endoscopy segment
** YTD, stock up 255.6%, while Hang Seng Biotech Index .HSBIO down 0.7%

($1 = 7.8420 Hong Kong dollars)

 (Reporting by Donny Kwok)
 ((donny.kwok@thomsonreuters.com))